Certified Pediatric Hematology Oncology Nurse (CPHON) Practice Exam

Transient Erythroblastopenia of childhood is primarily recognized as a benign, self-limiting condition most commonly seen in children aged 1 to 3 years. During this age, children are undergoing various physiological changes and are increasingly exposed to infections that may trigger this condition. The condition is characterized by a temporary decrease in erythroblast production in the bone marrow, leading to anemia. While it can be seen in infants or older children, the peak incidence falls within the 1 to 3-year age range, where it often resolves on its own without intervention. This age group is particularly vulnerable as they transition from the early dependent phase of life to more interactive social behaviors, leading to increased exposure to viral infections, such as parvovirus B19, that can be linked to this form of anemia. Understanding the specific age group associated with Transient Erythroblastopenia of childhood is crucial for timely diagnosis and appropriate management, ensuring that healthcare providers can distinguish this condition from other more serious forms of anemia that may warrant further investigation.